TGFB1 and systemic sclerosis: Increased expression levels of TGF-β receptor II (TGFBR2) in MSCs from SSc patients under basal conditions and enhanced SMAD3 activation followed by increased collagen mRNA synthesis was recently independently reported upon short-term TGF-β1 stimulation (up to 24 h) [19].